Radioimmunoguided surgery for colorectal cancer

American Journal of Surgery

Volumn 173, Issue 5, 1997, Pages 386-389

  Manayan, Rex C ^a   Hart, Michael J ^a   Friend, William G ^a,b  

^a SWEDISH MEDICAL CENTER   (United States)

^b Northwest Colon and Rectal Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; IODINE 125; MONOCLONAL ANTIBODY CC49; TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; ISOTOPE LABELING; MALE; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RADIOIMMUNOLOGY; SAFETY; SURGICAL TECHNIQUE;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; RADIOIMMUNODETECTION;

EID: 0030972786     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(97)00070-6     Document Type: Article

References (14)

1. Parker SL, Tong T, Bolden S, et al. Cancer statistics, 1996. CA Cancer J Clin. 1996; 25-27.
2. Chapuis PH, Dent OF, Fisher R, et al. A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg. 1985;72:698-702.
3. 125I B72.3 in patients with colorectal cancer. Arch Surg. 1991;126:349-352.
4. Arnold MW, Schneebaum S, Berens A, et al. Intraoperative detection of colorectal cancer with RIGS and CC49, a second generation monoclonal antibody. Ann Surg. 1992;216:627-632.
5. Hinkle GH, Nabi HA, Miller EA, et al. Radioimmunodetection of implanted tumors with gamma probe. NCE Monograph. 1987;3:83-87.
6. Scott NA, Wieand HS, Moertel CG, et al. Colorectal cancer: Dukes' stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy pattern. Arch Surg. 1987;122:1375.
7. Martin DT, Aitken DR, Thurston MO, et al. Successful experimental use of a self contained gamma detecting device. Curr Surg. 1984;41:193-197.
8. Sickle-Santanello BJ, O'Dwyer PJ, Mojzisik CM, et al. RIGS using the monoclonal antibody B72.3 in colorectal tumors. Dis Col Rect. 1987;30:761-764.
9. Molinolo A, Simpson JF, Thor A, et al. Enhanced tumor binding using immunohistochemical analyses by second generation anti-TAG-72 monoclonal antibody against monoclonal antibody B72.3 in human tissue. Cancer Res. 1990;50:1291-1298.
10. Arnold MW, Schneebaum S, Petty L, et al. RIGS challenges traditional decision making in primary colorectal cancer. Surgery. 1992;112:624-630.
11. Triozzi PL, Kim JA, Aldrich W, et al. Localization of tumor-reactive lymph node lymphocytes in vivo using radiolabeled monoclonal antibody. Cancer. 1994;73:580-589.
12. Schneebaum S, Arnold MW, Houchens DP, et al. The significance of intraoperative periportal lymph node metastasis identification in patients with colorectal carcinoma. Cancer. 1995; 75:2809-2817.
13. 125I-radiolabeled monoclonal antibody CC49. Cancer. 1996;77(4):613-620.
14. Arnold MW, Young DC, Hitchcock CL, et al. Radioimmunoguided surgery in primary colorectal carcinoma: an intraoperative prognostic tool and adjuvant to traditional staging. Am J Surg. 1995;170:315-318.